SUBSCRIBE
SUBSCRIBE
News   Drug Development

Akzo Nobel N.V. Says Asenapine May Be Delayed, Shares Fall

October 18, 2006 | 
1 min read
AMSTERDAM, Oct 18 (Reuters) - Dutch chemicals group Akzo Nobel warned of a delay in launching its most promising pipeline drug asenapine and missed quarterly earnings expectations, sending its shares sliding on Wednesday.

>>> Discuss This Story

Clinical research Phase 3 Europe
MORE ON THIS TOPIC
Concept World kidney day, handcraft paper blue kidneys and stethoscope on yellow background. Copy space. Banner.
IgA nephropathy
Otsuka energizes IgA neuropathy space with new Phase 3 Voyxact data
June 5, 2026
 · 
2 min read
 · 
Tristan Manalac
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Lymphoma
ADC Therapeutics nosedives on 27 deaths in confirmatory trial for lymphoma drug
June 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Insights
Rethinking hair loss treatment
June 4, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Futuristic digital speedometer with glowing lines and red needle, representing fast acceleration and advanced automotive technology. vector eps10
Funding
NewLimit snags $435M after seeing age reversal in human liver cells
June 3, 2026
 · 
2 min read
 · 
Gabrielle Masson